Key result
CRISPRidentify achieved 99% accuracy and a true negative rate of 1.0 in detecting CRISPR arrays, drastically reducing the false positive rate compared to existing tools.
Why the study?
Existing bioinformatics tools for detecting CRISPR arrays rely on fixed scoring of repetitive patterns, creating a need for a data-driven machine learning approach to differentiate true from false arrays.
CRISPRidentify is a machine learning-based tool that improves the specificity of CRISPR array detection in genomic sequences by drastically reducing false positive rates compared to existing tools.
Enhances CRISPR detection reliability; leaves open validation for cardiovascular genomic applications.
CRISPR–Cas are adaptive immune systems that degrade foreign genetic elements in archaea and bacteria. In carrying out their immune functions, CRISPR– Cas systems heavily rely on RNA components. These CRISPR (cr) RNAs are repeat-spacer units that are produced by processing of pre-crRNA, the transcript of CRISPR arrays, and guide Cas protein(s) to the cognate invading nucleic acids, enabling their destruction. Several bioinformatics tools have been developed to detect CRISPR arrays based solely on DNA sequences, but all these tools employ the same strategy of looking for repetitive patterns, which might correspond to CRISPR array repeats. The identified patterns are evaluated using a fixed, built-in scoring function, and arrays exceeding a cut-off value are reported. Here, we instead introduce a data-driven approach that uses machine learning to detect and differentiate true CRISPR arrays from false ones based on several features. Our CRISPR detection tool, CRISPRidentify, performs three steps: detection, feature extraction and classification based on manually curated sets of positive and negative examples of CRISPR arrays. The identified CRISPR arrays are then reported to the user accompanied by detailed annotation. We demonstrate that our approach identifies not only previously detected CRISPR arrays, but also CRISPR array candidates not detected by other tools. Compared to other methods, our tool has a drastically reduced false positive rate. In contrast to the existing tools, our approach not only provides the user with the basic statistics on the identified CRISPR arrays but also produces a certainty score as a practical measure of the likelihood that a given genomic region is a CRISPR array.
No takes yet. Share an insight, caveat, or question.
Mitrofanov et al. (2020) studied CRISPR array detection. CRISPRidentify vs. CRT, CRISPRCasFinder, and CRISPRDetect was evaluated on Accuracy of CRISPR array detection on the test dataset. CRISPRidentify achieved 99% accuracy and a true negative rate of 1.0 in detecting CRISPR arrays, drastically reducing the false positive rate compared to existing tools.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: